BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17712656)

  • 1. Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women.
    Lin X; Gao ES; Li D; Zhang M; Dou LX; Yuan W
    Acta Obstet Gynecol Scand; 2007; 86(9):1126-9. PubMed ID: 17712656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
    Bengtsson LP; Weström L
    Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
    Kouides PA; Byams VR; Philipp CS; Stein SF; Heit JA; Lukes AS; Skerrette NI; Dowling NF; Evatt BL; Miller CH; Owens S; Kulkarni R
    Br J Haematol; 2009 Apr; 145(2):212-20. PubMed ID: 19236375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
    Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and treatment of IUD-induced menorrhagia with antifibrinolytic and antiprostaglandin drugs].
    Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):291-4, 312. PubMed ID: 3443023
    [No Abstract]   [Full Text] [Related]  

  • 8. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
    Lakhani KP; Marsh MS; Purcell W; Hardiman P
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of menorrhagia with tranexamic acid. A clinical trial of an underestimated problem in general practice].
    Drøsdal H
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2907-10. PubMed ID: 8236193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.
    Freeman EW; Lukes A; VanDrie D; Mabey RG; Gersten J; Adomako TL
    Am J Obstet Gynecol; 2011 Oct; 205(4):319.e1-7. PubMed ID: 21777897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of four types of IUD in China on menstrual blood volume].
    Gao J
    Shengzhi Yu Biyun; 1986 Aug; 6(3):52-3. PubMed ID: 12268665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.
    Kriplani A; Kulshrestha V; Agarwal N; Diwakar S
    J Obstet Gynaecol; 2006 Oct; 26(7):673-8. PubMed ID: 17071438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid: a review of its use in the management of menorrhagia.
    Wellington K; Wagstaff AJ
    Drugs; 2003; 63(13):1417-33. PubMed ID: 12825966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial.
    Alanwar A; Abbas AM; Hussain SH; Elhawwary G; Mansour DY; Faisal MM; Elshabrawy A; Eltaieb E
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):365-370. PubMed ID: 30247074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E (alpha tocopherol) in the management of menorrhagia associated with the use of intrauterine contraceptive devices (IUCD).
    Dasgupta PR; Dutta S; Banerjee P; Majumdar S
    Int J Fertil; 1983; 28(1):55-6. PubMed ID: 6134690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life.
    Bushnell DM; Martin ML; Moore KA; Richter HE; Rubin A; Patrick DL
    Curr Med Res Opin; 2010 Dec; 26(12):2745-55. PubMed ID: 21043553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tranexamic acid on blood loss during orthognathic surgery: a randomized controlled trial.
    Choi WS; Irwin MG; Samman N
    J Oral Maxillofac Surg; 2009 Jan; 67(1):125-33. PubMed ID: 19070758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding.
    Lukes AS; Baker J; Eder S; Adomako TL
    Womens Health (Lond); 2012 Sep; 8(5):503-11. PubMed ID: 22934724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices.
    Davies AJ; Anderson AB; Turnbull AC
    Obstet Gynecol; 1981 Jan; 57(1):74-8. PubMed ID: 7005780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.